237 related articles for article (PubMed ID: 17889852)
41. Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.
Szílagyi M; Rivera VR; Neal D; Merrill GA; Poli MA
Toxicon; 2000 Mar; 38(3):381-9. PubMed ID: 10669027
[TBL] [Abstract][Full Text] [Related]
42. An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin.
Evans ER; Skipper PJ; Shone CC
J Appl Microbiol; 2009 Oct; 107(4):1384-91. PubMed ID: 19426271
[TBL] [Abstract][Full Text] [Related]
43. A label-free biosensor assay for botulinum neurotoxin B in food and human serum.
Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C
Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347
[TBL] [Abstract][Full Text] [Related]
44. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
Yang GH; Kim KS; Kim HW; Jeong ST; Huh GH; Kim JC; Jung HH
Toxicon; 2004 Jul; 44(1):19-25. PubMed ID: 15225558
[TBL] [Abstract][Full Text] [Related]
45. Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells.
Pellett S; Du ZW; Pier CL; Tepp WH; Zhang SC; Johnson EA
Biochem Biophys Res Commun; 2011 Jan; 404(1):388-92. PubMed ID: 21130748
[TBL] [Abstract][Full Text] [Related]
46. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW
Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795
[TBL] [Abstract][Full Text] [Related]
47. Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum.
Cheng LW; Stanker LH
J Agric Food Chem; 2013 Jan; 61(3):755-60. PubMed ID: 23265581
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
49. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
50. Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.
Bagramyan K; Kaplan BE; Cheng LW; Strotmeier J; Rummel A; Kalkum M
Anal Chem; 2013 Jun; 85(11):5569-76. PubMed ID: 23656526
[TBL] [Abstract][Full Text] [Related]
51. Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors.
Ruthel G; Burnett JC; Nuss JE; Wanner LM; Tressler LE; Torres-Melendez E; Sandwick SJ; Retterer CJ; Bavari S
Toxins (Basel); 2011 Mar; 3(3):207-17. PubMed ID: 22069707
[TBL] [Abstract][Full Text] [Related]
52. The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.
Rasetti-Escargueil C; Avril A; Miethe S; Mazuet C; Derman Y; Selby K; Thullier P; Pelat T; Urbain R; Fontayne A; Korkeala H; Sesardic D; Hust M; Popoff MR
Toxins (Basel); 2017 Oct; 9(10):. PubMed ID: 28974033
[TBL] [Abstract][Full Text] [Related]
53. Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases.
Tremblay JM; Kuo CL; Abeijon C; Sepulveda J; Oyler G; Hu X; Jin MM; Shoemaker CB
Toxicon; 2010 Nov; 56(6):990-8. PubMed ID: 20637220
[TBL] [Abstract][Full Text] [Related]
54. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.
Stahl C; Unger L; Mazuet C; Popoff M; Straub R; Frey J
Vaccine; 2009 Sep; 27(41):5661-6. PubMed ID: 19646409
[TBL] [Abstract][Full Text] [Related]
55. A new neutralizing antibody against botulinum neurotoxin B recognizes the protein receptor binding sites for synaptotagmins II.
Wang H; Li T; Shi J; Cai K; Hou X; Wang Q; Xiao L; Tu W; Liu H; Gao X
Microbes Infect; 2010 Nov; 12(12-13):1012-8. PubMed ID: 20650331
[TBL] [Abstract][Full Text] [Related]
56. Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies.
Nuss JE; Ruthel G; Tressler LE; Wanner LM; Torres-Melendez E; Hale ML; Bavari S
J Biomol Screen; 2010 Jan; 15(1):42-51. PubMed ID: 19965805
[TBL] [Abstract][Full Text] [Related]
57. Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis.
Wang J; Zurawski TH; Meng J; Lawrence GW; Aoki KR; Wheeler L; Dolly JO
FASEB J; 2012 Dec; 26(12):5035-48. PubMed ID: 22942075
[TBL] [Abstract][Full Text] [Related]
58. A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo.
Adekar SP; Al-Saleem FH; Elias MD; Rybinski KA; Simpson LL; Dessain SK
Hybridoma (Larchmt); 2008 Apr; 27(2):65-9. PubMed ID: 18642670
[TBL] [Abstract][Full Text] [Related]
59. Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins.
Adekar SP; Jones RM; Elias MD; Al-Saleem FH; Root MJ; Simpson LL; Dessain SK
J Immunol Methods; 2008 Apr; 333(1-2):156-66. PubMed ID: 18313069
[TBL] [Abstract][Full Text] [Related]
60. Botulinum Neurotoxins (BoNTs)-Antibody and Vaccine.
Lou J; Marks JD
Toxins (Basel); 2018 Nov; 10(12):. PubMed ID: 30486254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
